How is the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the lateral flow immunoassay (lfia) based rapid test market grown over the years?
The market size for the rapid test based on the lateral flow immunoassay (LFIA) has experienced a substantial decrease in recent years. The market witnessed a slump from $8.03 billion in 2024 to $7.23 billion in 2025, registering a compound annual growth rate (CAGR) of -9.9%. This downturn during the historic period could be ascribed to issues such as inadequate sensitivity and specificity, complications of multiplexing, features of cross-reactivity, challenges relating to storage and shelf-life, and limited quantitative ability.
What Is the forecasted market size and growth rate for the lateral flow immunoassay (lfia) based rapid test market?
The market size of in-app purchases is projected to witness an impressive surge in the coming years, with anticipation to reach $657.18 billion by 2029 and a compound annual growth rate (CAGR) of 26.4%. The expansion within the projected timeline can be ascribed to subscription-based models, growth in emerging markets, and enhanced cross-platform integration. The forecast period will see trends such as the dominance of mobile gaming, subscription models, integration of augmented reality (AR), along with an increased emphasis on personalization, customization, and digital goods and services.
Get your lateral flow immunoassay (lfia) based rapid test market report here!
What are the major factors driving growth in the lateral flow immunoassay (lfia) based rapid test market?
The advancement of the lateral flow immunoassay (LFIA) based rapid test market may be stymied due to ongoing quality control issues. Many law firms have experienced strained profit margins due to the rising costs of operations, which includes salaries and investments in technology. In June of 2023, PLOS, a non-profit organization based in the United States, noted that LFIA products in the market were not consistently achieving high standards for reliability and specificity. A retrospective study on four different LFIA tests showed a wide range of diagnostic performance, with some tests having an accuracy for IgG detection as low as 47%.
What key areas define the segmentation of the global lateral flow immunoassay (lfia) based rapid test Market?
The lateral flow immunoassay (LFIA) based rapid test market covered in this report is segmented –
1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay
2) By Application: Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications
3) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users
Subsegments:
1) By Competitive Assay: Direct Competitive Assays, Indirect Competitive Assays
2) By Sandwich Assay: Single-step Sandwich Assays, Two-step Sandwich Assays
3) By Multiplex Detection Assay: Multi-analyte Assays, Simultaneous Detection Of Various Targets
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3293&type=smp
What are the top market players propelling the growth of the lateral flow immunoassay (lfia) based rapid test industry?
Major companies operating in the lateral flow immunoassay (LFIA) based rapid test market include Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton, Dickinson and Company, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience® Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH, Charles River Laboratories, EKF Diagnostics, Launch Diagnostics, Diagnostic Instruments Ltd, Qiagen N.V., Merck KGaA, XPhyto Therapeutics, 3a Diagnostics, Roche Holding AG, BATM, Biomaxima, SensDx, Vitrosens Biotechnology, Bioeasy Biotechnology, Fujirebio, Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, CTK Biotech
What are the key trends shaping the future of the lateral flow immunoassay (lfia) based rapid test market?
Major corporations in the lateral flow immunoassay (LFIA) rapid test sector are prioritizing technologies like qPCR technology to upgrade the sensitivity and specificity of their screenings, quicken the detection process, and widen the scope of detectable pathogens or biomarkers. This ultimately aids in the provision of more dependable and precise diagnostic tools for different medical applications. The qPCR (quantitative polymerase chain reaction) technology, a molecular biology method, is used for amplifying and measuring DNA or RNA sequences in real time. It allows the accurate gauging of gene expression levels or the detection of specific pathogens across various samples. For instance, in November 2023, the LightCycler PRO System was introduced by F. Hoffmann-La Roche AG, a pharmaceutical firm based in Switzerland. The LightCycler PRO, enhancing Roche’s standing of qPCR systems, employs gold-standard technology for premier quality, precision, and reliability, which are essential for precise patient diagnosis and efficient clinical decision-making.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3293
What regions are dominating the lateral flow immunoassay (lfia) based rapid test market growth?
North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2024. Asia-Pacific was the second largest region in the global lateral flow immunoassay (LFIA) based rapid test market. The regions covered in the lateral flow immunoassay (LFIA) based rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Veterinary Laboratory Testing Services Global Market Report 2024
Pharma Microbiology Testing Kits Global Market Report 2024
Veterinary Diagnostic Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
